Direkt zum Inhalt
Merck
  • Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.

Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.

Journal of medicinal chemistry (2010-01-15)
Manthena V S Varma, R Scott Obach, Charles Rotter, Howard R Miller, George Chang, Stefanus J Steyn, Ayman El-Kattan, Matthew D Troutman
ZUSAMMENFASSUNG

Oral bioavailability (F) is a product of fraction absorbed (Fa), fraction escaping gut-wall elimination (Fg), and fraction escaping hepatic elimination (Fh). In this study, using a database comprised of Fa, Fg, Fh, and F values for 309 drugs in humans, an analysis of the interrelation of physicochemical properties and the individual parameters was carried out in order to define the physicochemical space for optimum human oral bioavailability. Trend analysis clearly indicated molecular weight (MW), ionization state, lipophilicity, polar descriptors, and free rotatable bonds (RB) influence bioavailability. These trends were due to a combination of effects of the properties on Fa and first-pass elimination (Fg and Fh). Higher MW significantly impacted Fa, while Fg and Fh decreased with increasing lipophilicity. Parabolic trends were observed for bioavailability with polar descriptors. Interestingly, RB has a negative effect on all three parameters, leading to its pronounced effect on bioavailability. In conclusion, physicochemical properties influence bioavailability with typically opposing effects on Fa and first-pass elimination. This analysis may provide a rational judgment on the physicochemical space to optimize oral bioavailability.

MATERIALIEN
Produktnummer
Marke
Produktbeschreibung

Sigma-Aldrich
Dexamethason, powder, BioReagent, suitable for cell culture, ≥97%
Sigma-Aldrich
Koffein, powder, ReagentPlus®
Sigma-Aldrich
Rifampicin, ≥95% (HPLC), powder or crystals
Sigma-Aldrich
(−)-Nikotin, ≥99% (GC), liquid
Sigma-Aldrich
Dexamethason, ≥98% (HPLC), powder
Sigma-Aldrich
Ibuprofen, ≥98% (GC)
Sigma-Aldrich
Ampicillin, anhydrous, 96.0-102.0% (anhydrous basis)
Sigma-Aldrich
Theophyllin, anhydrous, ≥99%, powder
Sigma-Aldrich
Erythromycin, BioReagent, suitable for cell culture
Sigma-Aldrich
Trimethoprim, ≥98.5%
Sigma-Aldrich
Ciprofloxacin, ≥98% (HPLC)
Sigma-Aldrich
Hydroxyharnstoff, 98%, powder
Sigma-Aldrich
Indomethacin, 98.0-102.0%, meets EP testing specifications
Sigma-Aldrich
Koffein, anhydrous, 99%, FCC, FG
Sigma-Aldrich
Tetracyclin, 98.0-102.0% (HPLC)
Sigma-Aldrich
Amoxicillin, 95.0-102.0% anhydrous basis
Sigma-Aldrich
Levofloxacin, 98.0-102.0% anhydrous basis (HPLC)
Sigma-Aldrich
4-Acetamidophenol, BioXtra, ≥99.0%
Sigma-Aldrich
Cyclosporin A, 97.0-101.5% (on dried basis)
Sigma-Aldrich
Prednisolon, ≥99%
Sigma-Aldrich
Prednison, ≥98%
Supelco
Schmelzpunktstandard 235-237°C, analytical standard
Sigma-Aldrich
4-Acetamidophenol, meets USP testing specifications, 98.0-102.0%, powder
Sigma-Aldrich
Nifedipin, ≥98% (HPLC), powder
Sigma-Aldrich
Furosemid
Sigma-Aldrich
Ofloxacin, fluoroquinolone antibiotic
Sigma-Aldrich
Trimethoprim, ≥99.0% (HPLC)
Sigma-Aldrich
4-Acetamidophenol, analytical standard
Sigma-Aldrich
5-Fluorcytosin, nucleoside analog
Sigma-Aldrich
Rifampicin, suitable for plant cell culture, BioReagent, ≥95% (HPLC), powder or crystals